Accelerated Biosciences Corp.
June 16, 2025
Company Presentation
Regenerative Medicine
Accelerated Biosciences is a regenerative medicine company commercializing the human Trophoblast Stem Cell (hTSC). hTSCs are the earliest stem cells that can be sourced without ethical issues. The holy grail combination of scale and natural immune privilege makes it an ideal starting cell source for cell and gene therapies. We provide GMP cells with over 120 patents to accelerate therapeutic developers’ product time to market. Our indications are Resistant Hypertension, Psoriasis, Parkinson’s Disease, and Type 1 Diabetes. We are collaborating with the National Institute on Aging (NIH) on cell senescence and reversing biological age.
Company HQ City:
Philadelphia
Company HQ State:
PA
Company HQ Country:
United States
Year Founded:
2013
Lead Product in Development:
hTSC-derived exosomes (ABX-001) for resistant hypertension and psoriasis.
CEO
Yuta Lee
Year Founded
2013
Development Phase of Lead Product
Pre-Clinical
Number of Unlicensed Products Looking for Licensing
1. hTSC
2. hTSC-derived iPSC
3. hTSC exosomes
When you expect your next catalyst update?
FDA DMF & FDA Interact
What is your next catalyst (value inflection) update?
Q4 2025
Website
https://www.acceleratedbio.com/
Primary Speaker
)
)
)
)
){kind=logo}
)
){kind=logo}